Creative Medical Technology Holdings, Inc. Proceeds from Sale of Equity Method Investments
Creative Medical Technology Holdings, Inc. (CELZ) reported Proceeds from Sale of Equity Method Investments of $0 for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfEquityMethodInvestments · last filed 2025-08-08
- Creative Medical Technology Holdings, Inc. proceeds from sale of equity method investments for the quarter ending 2025-06-30 was $0.00.
- Creative Medical Technology Holdings, Inc. proceeds from sale of equity method investments for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Creative Medical Technology Holdings, Inc. proceeds from sale of equity method investments for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- Creative Medical Technology Holdings, Inc. proceeds from sale of equity method investments for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- Creative Medical Technology Holdings, Inc. proceeds from sale of equity method investments for fiscal 2024 was $6.52M, a 75.30% decline from fiscal 2023.
- Creative Medical Technology Holdings, Inc. proceeds from sale of equity method investments for fiscal 2023 was $26.40M.
- Creative Medical Technology Holdings, Inc. proceeds from sale of equity method investments for fiscal 2022 was $0.00.
| Period end | Proceeds from Sale of Equity Method Investments 3 month | Proceeds from Sale of Equity Method Investments 6 month | Proceeds from Sale of Equity Method Investments 9 month | Proceeds from Sale of Equity Method Investments 12 month |
|---|---|---|---|---|
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $0.00 10-Q · filed 2025-08-08 | $0.00 derived: sum of 3 quarters · filed 2025-08-08 | $0.00 derived: sum of 4 quarters · filed 2025-08-08 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-09 | $0.00 derived: sum of 2 quarters · filed 2025-05-09 | $0.00 derived: sum of 3 quarters · filed 2025-05-09 | $0.00 derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $0.00 derived: sum of 2 quarters · filed 2025-03-14 | $0.00 derived: sum of 3 quarters · filed 2025-08-08 | $6.52M 10-K · filed 2025-03-14 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $0.00 derived: sum of 2 quarters · filed 2025-08-08 | $6.52M 10-Q · filed 2024-11-08 | $23.87M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $6.52M 10-Q · filed 2025-08-08 | $23.87M derived: sum of 3 quarters · filed 2025-08-08 | $27.87M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $6.52M 10-Q · filed 2025-05-09 | $23.87M derived: sum of 2 quarters · filed 2025-05-09 | $27.87M derived: sum of 3 quarters · filed 2025-05-09 | $27.88M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $17.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $21.35M derived: sum of 2 quarters · filed 2025-03-14 | $21.36M derived: sum of 3 quarters · filed 2025-03-14 | $26.40M 10-K · filed 2025-03-14 |
| 2023-09-30 | $4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $4.01M derived: sum of 2 quarters · filed 2024-11-08 | $9.05M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $11.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $5.05M 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | $5.04M 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | $0.00 10-K · filed 2024-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |